These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan. Chella N, Tadikonda R. Drug Dev Ind Pharm; 2015 Jun; 41(6):888-97. PubMed ID: 24796274 [Abstract] [Full Text] [Related]
3. Co-Amorphous Simvastatin-Nifedipine with Enhanced Solubility for Possible Use in Combination Therapy of Hypertension and Hypercholesterolemia. Martínez-Jiménez C, Cruz-Angeles J, Videa M, Martínez LM. Molecules; 2018 Aug 28; 23(9):. PubMed ID: 30154310 [Abstract] [Full Text] [Related]
4. Enhanced dissolution and oral bioavailability of valsartan solid dispersions prepared by a freeze-drying technique using hydrophilic polymers. Xu WJ, Xie HJ, Cao QR, Shi LL, Cao Y, Zhu XY, Cui JH. Drug Deliv; 2016 Aug 28; 23(1):41-8. PubMed ID: 24735247 [Abstract] [Full Text] [Related]
5. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan. Lee JY, Kang WS, Piao J, Yoon IS, Kim DD, Cho HJ. Drug Des Devel Ther; 2015 Aug 28; 9():2745-56. PubMed ID: 26045660 [Abstract] [Full Text] [Related]
8. Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan. Huang Y, Zhang Q, Wang JR, Lin KL, Mei X. Pharm Dev Technol; 2017 Feb 28; 22(1):69-76. PubMed ID: 27050301 [Abstract] [Full Text] [Related]
11. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. Nielsen LH, Gordon S, Holm R, Selen A, Rades T, Müllertz A. Eur J Pharm Biopharm; 2013 Nov 28; 85(3 Pt B):942-51. PubMed ID: 24075980 [Abstract] [Full Text] [Related]
12. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Hecq J, Deleers M, Fanara D, Vranckx H, Amighi K. Int J Pharm; 2005 Aug 11; 299(1-2):167-77. PubMed ID: 15996838 [Abstract] [Full Text] [Related]
13. Enhanced dissolution of valsartan-vanillin binary co-amorphous system loaded in mesoporous silica particles. Hashim Ali K, Mohsin Ansari M, Ali Shah F, Ud Din F, Abdul Basit M, Kim JK, Zeb A. J Microencapsul; 2019 Jan 11; 36(1):10-20. PubMed ID: 30719944 [Abstract] [Full Text] [Related]
14. Solid-state characterization of nifedipine solid dispersions. Vippagunta SR, Maul KA, Tallavajhala S, Grant DJ. Int J Pharm; 2002 Apr 02; 236(1-2):111-23. PubMed ID: 11891075 [Abstract] [Full Text] [Related]
15. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes. Yan YD, Sung JH, Kim KK, Kim DW, Kim JO, Lee BJ, Yong CS, Choi HG. Int J Pharm; 2012 Jan 17; 422(1-2):202-10. PubMed ID: 22085435 [Abstract] [Full Text] [Related]
16. Evaluation of Drug Dissolution Rate in Co-amorphous and Co-crystal Binary Drug Delivery Systems by Thermodynamic and Kinetic Methods. Hu C, Zhang F, Fan H. AAPS PharmSciTech; 2021 Jan 03; 22(1):21. PubMed ID: 33389277 [Abstract] [Full Text] [Related]